Comparison of 30-day direct medical costs of azithromycin and levofloxacin for patients hospitalized with community-acquired pneumonia

被引：0
|
作者：
Matchar, DB
Samsa, GP
Harnett, J
Wilson, J
机构：
[1] Duke Univ, Durham, NC 27706 USA
[2] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62489-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：357 / 357
页数：1
相关论文
共 50 条
  • [1] The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
    Eric M Mortensen
    Marcos I Restrepo
    Antonio Anzueto
    Jacqueline Pugh
    Respiratory Research, 6
  • [2] The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
    Mortensen, EM
    Restrepo, MI
    Anzueto, A
    Pugh, J
    RESPIRATORY RESEARCH, 2005, 6 (1)
  • [3] 30-day mortality in UK patients with bacteraemic community-acquired pneumonia
    Melzer, M.
    Welch, C.
    INFECTION, 2013, 41 (05) : 1005 - 1011
  • [4] 30-day mortality in UK patients with bacteraemic community-acquired pneumonia
    M. Melzer
    C. Welch
    Infection, 2013, 41 : 1005 - 1011
  • [5] The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia
    Mortensen E.M.
    Restrepo M.I.
    Anzueto A.
    Pugh J.
    BMC Pulmonary Medicine, 5 (1)
  • [6] Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia
    Goldstein, Lee Hilary
    Gabin, Ahmad
    Fawaz, Abdallah
    Freedberg, Nahum Adam
    Schwartz, Naama
    Elias, Mazen
    Saliba, Walid
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (10) : 1042 - 1048
  • [7] Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia
    Chakrabarti, Biswajit
    Lane, Steven
    Jenks, Tom
    Higgins, Joanne
    Kanwar, Elizabeth
    Allen, Martin
    Wotton, Dan
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [8] Impact of Antibiotic Treatment on 30-Day Readmissions for Community-Acquired Pneumonia
    Kim, Angela C.
    Smith, Miriam A.
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (03) : E331 - E332
  • [9] Marked Reduction in 30-Day Mortality Among Elderly Patients with Community-acquired Pneumonia
    Ruhnke, Gregory W.
    Coca-Perraillon, Marcelo
    Kitch, Barrett T.
    Cutler, David M.
    AMERICAN JOURNAL OF MEDICINE, 2011, 124 (02): : 171 - U117
  • [10] 5-DAY AZITHROMYCIN IN THE TREATMENT OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
    HOPKINS, S
    WILLIAMS, D
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (09): : 915 - 925
12345